FDA Calls Omeros' Kidney Disorder Drug a Breakthrough Post author:Sam Post published:June 12, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like These are the Top 5 Biotech Stocks (So Far) June 25, 2017 Biogen Shows Off More Positive Alzheimer???s Trial Data August 27, 2017 Boehringer Ingelheim Initiates Phase IIa Study Of Compound Acquired From Pharmaxis In Debilitating Liver Disease NASH August 24, 2017
Boehringer Ingelheim Initiates Phase IIa Study Of Compound Acquired From Pharmaxis In Debilitating Liver Disease NASH August 24, 2017